Steven Cohen’s DataMeds AI MEDS Stock Holding History

Steven Cohen’s Portfolio MEDS Stock Details MEDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-546	Closed	-$2.63K	–	4710
2026 Q1	$2.63K	Buy	546 +254	+87%	+$3.49K	﹤0.01%	3704
2025 Q4	$5.84K	Buy	+292	New	+$8.56K	﹤0.01%	3850

Other funds holding MEDS

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Steven Cohen's MEDS Position: Q2 2026 in Review

Steven Cohen sold out of DataMeds AI (MEDS) in Q2 2026, closing a stake of 546 shares — an estimated $2.63K sold.

Steven Cohen first reported a position in MEDS in Q4 2025 and held it in 2 quarters. The position peaked at $5.84K in Q4 2025. 10 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

Steven Cohen reported no remaining DataMeds AI position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 546 DataMeds AI shares in Q2 2026, an estimated $2.63K.
Steven Cohen first reported a position in DataMeds AI in Q4 2025 and held it in 2 quarters.
Steven Cohen's DataMeds AI position peaked at $5.84K in Q4 2025.
10 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.